Danish AI Lab Sevren Launches Push for Compute-Efficient Open-Source Models

Sevren, spun out from the Danish fintech Monthio, was announced as a new AI lab focused on open‑source, compute‑efficient models. Its core technologies, HEIMR and Faberon, aim to lower the hardware requirements for large‑context AI, enabling advanced models to run on smaller devices. The lab secured free access to Denmark’s sovereign AI supercomputer Gefion and is backed by a roster of high‑profile European angels. Sevren positions itself within the European AI sovereignty debate, seeking to turn the continent’s compute scarcity into a competitive advantage.

Cambridge RNA Therapeutics Startup Undecimal Bio Raises €16 Million to Expand AI-Powered Delivery Platform

Cambridge‑based spin‑out Undecimal Bio secured €16 million in Seed funding, co‑led by 4BIO Capital and IQ Capital, to develop its AI‑driven DELiveri platform that identifies conjugates for precise siRNA delivery to non‑liver tissues, starting with renovascular diseases.

Italian AI Startup ConnectEd Mind Partners with Rheinmetall Italia on Dual-Use Cognitive Security Solutions

Italian startup ConnectEd Mind teamed up with Rheinmetall Italia to integrate its AI‑driven cognitive security expertise with Rheinmetall’s Brain platform, aiming to create dual‑use solutions that enhance decision‑making and training for both defence and civil applications.

Danish-Lithuanian Drone Maker Monopulse Secures €2M+ to Scale EW-Resistant UAV Production

Monopulse, a Danish‑Lithuanian UAV maker founded in 2021, secured more than €2 million from investors including Coinvest Capital, Plug and Play and NGL Ventures. The funding will boost production, R&D and market expansion for its electronic‑warfare‑resistant drones used by NATO forces.

London-based Scarlet raises $50M Series B to expand AI medical device certification globally

Scarlet, a London‑based certification body specialized in AI and software medical devices, closed a $50 million Series B led by Headline. The funding will support its expansion into the US and APAC markets, increase its team of AI reviewers, and extend its certification services, positioning it as the only EU‑designated notified body focused on AI‑native medical devices.